[关键词]
[摘要]
目的:探讨超声乳化联合人工晶状体(IOL)植入术治疗原发性闭角型青光眼合并白内障的临床疗效及应用价值。
方法:将我院行手术治疗原发性闭角型青光眼合并白内障患者98例130眼采用随机数字法分为观察组和对照组,每组各65眼,对照组行周边虹膜切除手术,观察组采用超声乳化联合IOL植入手术治疗,记录两组患者手术情况和治疗效果。
结果:观察组手术后7d眼压14.11±1.97mmHg,术后1mo眼压14.01±1.65mmHg,术后3mo眼压14.16±1.45mmHg; 对照组手术后7d眼压17.46±2.31mmHg,术后1mo眼压17.15±2.27mmHg,术后3mo眼压17.03±2.18mmHg,经统计学分析差异有统计学意义(P<0.05)。观察组治疗后视力0.73±0.11,前房深度4.58±0.85mm; 对照组治疗后视力0.60±0.07,前房深度4.01±0.51mm,组间对比差异有统计学意义(P<0.05)。观察组手术并发症发生率为4.6%,对照组手术并发症发生率15.4%,组间对比差异有统计学意义(P<0.05)。观察组术后视野缺损值为-19.78±4.65dB,对照组术后视野缺损值为-16.13±3.03dB,组间对比差异有统计学意义(P<0.05)。
结论:超声乳化联合IOL植入手术治疗原发性闭角型青光眼合并白内障临床疗效可靠,术后并发症少,安全有效。
[Key word]
[Abstract]
AIM:To explore the surgery clinical curative effect and application value of phacoemulsification combined intraocular lens implantation in the treatment of primary angle-closure glaucoma with cataract.
METHODS: Totally 98 patients(130 eyes)with primary angle-closure glaucoma and cataract were divided into observation group and control group by random number method, 65 eyes in each group. Control group were treated with peripheral iris resection surgery, observation group with phacoemulsification combined intraocular lens implantation. Curative effect of two groups were recorded.
RESULTS: Intraocular pressure(IOP)of observation group was 14.11±1.97mmHg at 7d after operations, 14.01±1.65mmHg at 1mo after operations, 14.16±1.45mmHg at 3mo, those of control group were 17.46±2.31mmHg, 17.15±2.27mmHg, 17.03±2.18mmHg, and the differences were significant(P<0.05). Visual acuity and anterior chamber depth of observation group were 0.73±0.11 and 4.58±0.85mm after operations, those of control group were 0.60±0.07 and 4.01±0.51mm, and the differences were significant(P<0.05). The complication incidence of observation group was 4.6%, that of control group was 15.4%, and the differences were significant(P<0.05). Visual field defect of observation group was -19.78±4.65dB, that of control group was -16.13±3.03dB, and the differences were significant(P<0.05).
CONCLUSION: Phacoemulsification combined intraocular lens implantation in the treatment of primary angle-closure glaucoma with cataract is reliable, less postoperative complications, safe, effective and worthy to be promoted.
[中图分类号]
[基金项目]